Irinotecan eluting beads-transarterial chemoembolization using Callispheres® microspheres is an effective and safe approach in treating unresectable colorectal cancer liver metastases

[1] Akgul O(2014)Role of surgery in colorectal cancer liver metastases World J Gastroenterol 20 6113-6122

[2] Cetinkaya E(2018)Colorectal cancer liver metastases - a population-based study on incidence, management and survival BMC Cancer 18 78-3077

[3] Ersoz S(2014)Immune escape mechanisms in colorectal cancer pathogenesis and liver metastasis J Immunol Res 2014 686879-2564

[4] Engstrand J(2019)Comparison of response and outcomes of drug-eluting bead chemoembolization (DEB-TACE) versus radioembolization (TARE) for patients with colorectal cancer liver metastases Anticancer Res 39 3071-1395

[5] Nilsson H(2017)Current status and future perspectives on treatment of liver metastasis in colorectal cancer (Review) Oncol Rep 37 2553-1190

[6] Stromberg C(2012)Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study Anticancer Res 32 1387-271

[7] Pancione M(2016)Efficacy and toxicity of hepatic intra-arterial drug-eluting (irinotecan) bead (DEBIRI) therapy in irinotecan-refractory unresectable colorectal liver metastases World J Surg 40 1178-551

[8] Giordano G(2020)HMGB1, the next predictor of transcatheter arterial chemoembolization for liver metastasis of colorectal cancer? Front Oncol 10 572418-191

[9] Remo A(2020)The Comprehensive analysis of efficacy and safety of CalliSpheres((R)) drug-eluting beads transarterial chemoembolization in 367 liver cancer patients: a multiple-center Cohort Study Oncol Res 28 249-6598

[10] Mokkarala M(2016)Development of CalliSpheres(R) embolic microspheres Zhonghua Gan Zang Bing Za Zhi 24 549-1220

[1] Akgul O(2014)Role of surgery in colorectal cancer liver metastases World J Gastroenterol 20 6113-6122

[2] Cetinkaya E(2018)Colorectal cancer liver metastases - a population-based study on incidence, management and survival BMC Cancer 18 78-3077

[3] Ersoz S(2014)Immune escape mechanisms in colorectal cancer pathogenesis and liver metastasis J Immunol Res 2014 686879-2564

[4] Engstrand J(2019)Comparison of response and outcomes of drug-eluting bead chemoembolization (DEB-TACE) versus radioembolization (TARE) for patients with colorectal cancer liver metastases Anticancer Res 39 3071-1395

[5] Nilsson H(2017)Current status and future perspectives on treatment of liver metastasis in colorectal cancer (Review) Oncol Rep 37 2553-1190

[6] Stromberg C(2012)Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study Anticancer Res 32 1387-271

[7] Pancione M(2016)Efficacy and toxicity of hepatic intra-arterial drug-eluting (irinotecan) bead (DEBIRI) therapy in irinotecan-refractory unresectable colorectal liver metastases World J Surg 40 1178-551

[8] Giordano G(2020)HMGB1, the next predictor of transcatheter arterial chemoembolization for liver metastasis of colorectal cancer? Front Oncol 10 572418-191

[9] Remo A(2020)The Comprehensive analysis of efficacy and safety of CalliSpheres((R)) drug-eluting beads transarterial chemoembolization in 367 liver cancer patients: a multiple-center Cohort Study Oncol Res 28 249-6598

[10] Mokkarala M(2016)Development of CalliSpheres(R) embolic microspheres Zhonghua Gan Zang Bing Za Zhi 24 549-1220